Amundi Sells 6,963 Shares of Chemed Corporation $CHE

Amundi cut its position in Chemed Corporation (NYSE:CHE - Free Report) by 18.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,827 shares of the company's stock after selling 6,963 shares during the period. Amundi owned about 0.21% of Chemed worth $19,088,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alpine Bank Wealth Management purchased a new stake in shares of Chemed in the first quarter worth $29,000. HM Payson & Co. purchased a new stake in shares of Chemed in the first quarter worth $30,000. SVB Wealth LLC purchased a new stake in shares of Chemed in the first quarter worth $30,000. Whipplewood Advisors LLC increased its stake in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after purchasing an additional 18 shares in the last quarter. Finally, WPG Advisers LLC purchased a new stake in shares of Chemed in the first quarter worth $32,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on CHE. Bank of America cut their target price on shares of Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a research note on Wednesday. Jefferies Financial Group raised shares of Chemed from a "hold" rating to a "buy" rating and raised their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. Oppenheimer cut their target price on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Finally, Royal Bank Of Canada cut their target price on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $578.50.

Chemed Stock Performance

Shares of NYSE:CHE traded down $11.89 on Friday, reaching $446.00. The company's stock had a trading volume of 160,245 shares, compared to its average volume of 167,896. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The company has a market cap of $6.50 billion, a P/E ratio of 22.93, a PEG ratio of 2.66 and a beta of 0.46. The company has a 50-day simple moving average of $451.83 and a 200 day simple moving average of $530.93.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The business had revenue of $618.80 million during the quarter, compared to analysts' expectations of $650.60 million. During the same period in the previous year, the business earned $5.47 earnings per share. The business's quarterly revenue was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities research analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. This is an increase from Chemed's previous quarterly dividend of $0.50. Chemed's dividend payout ratio is 12.34%.

Insiders Place Their Bets

In other Chemed news, EVP Nicholas Michael Westfall sold 10,012 shares of Chemed stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total value of $4,224,162.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Patrick P. Grace sold 150 shares of the firm's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director owned 3,397 shares of the company's stock, valued at $1,574,135.83. This trade represents a 4.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 3.29% of the company's stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.